Collectively, these studies show conflicting results regarding the role of the CB2 receptor in atopic dermatitis, as both the CB2 receptor antagonist/inverse agonist JTE-907 and the CB2 agonist S-777469 produced positive effects. This evidence concerns the gene CNR2 and atopic eczema.